Nina Rautonen;Heli Putaala;Arthur Ouwehand;Kirsti Tiihonen;Marta Korczynska;Wouter Herman Noordman
发明人:
Nina Rautonen,Heli Putaala,Arthur Ouwehand,Kirsti Tiihonen,Marta Korczynska,Wouter Herman Noordman
申请号：
US12162160
公开号：
US08257695B2
申请日:
2007.01.28
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Use of at least one strain of a microorganism and/or a metabolite thereof in the manufacture of a support for administration to a subject for modulating satiety signalling, wherein the support is a pharmaceutically acceptable support or a food product. Suitably, the at least one strain of a microorganism and/or a metabolite thereof may be administered to the subject for the treatment and/or prevention of excess weight and/or a disease caused by excess weight. Likewise, the at least one strain of a microorganism and/or a metabolite thereof is administered to the subject for the treatment and/or prevention of obesity and/or a caused by obesity. Preferably, the microorganism is a probiotic microorganism. Suitably the microorganism may be a lactic acid bacterium. Li one embodiment the microorganism is a strain of Lactobacillus spp. and/or Bifidobacterium spp., for example a strain of Lactobacillus acidophilus, L. curvatus, L. salivarius and/or B. lactis.
